- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about PSTV
Recent news which mentions PSTV
21 Stocks Moving in Wednesday's Pre-Market Session
January 05, 2022
From Benzinga
45 Biggest Movers From Yesterday
January 05, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 04, 2022
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 04, 2022
From Benzinga
The Daily Biotech Pulse: Liquidia Jumps On New CEO Appointment, Spectrum, Aravive Secure New Funding, Allena To Explore Strategic Alternatives
January 04, 2022
From Benzinga
Plus Therapeutics Shares Shine After Two Milestones To Manufacture Its Lead Radiotherapeutic
January 04, 2022
Tickers
PSTV
From Benzinga
Plus Therapeutics Announces Positive Interim Data in Clinical Trial for New Brain Cancer Treatment
December 02, 2021
Tickers
PSTV
From Benzinga
Plus Therapeutics' Targeted Radiotherapy Shows Encouraging Overall Survival In Brain Tumour Trial
November 18, 2021
Tickers
PSTV
From Benzinga
Plus Therapeutics Says Its Radiation Technology is The Most Precise in Targeting and Killing Cancer Cells
November 18, 2021
Tickers
PSTV
From Benzinga
The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More
November 14, 2021
From Benzinga
This Company's Innovative Targeted Radiation Therapy Could Offer Potential Hope for Cancer Patients
November 11, 2021
From Benzinga
3 Penny Stocks Insiders Are Buying
October 29, 2021
From Benzinga
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
From Benzinga
Earnings Scheduled For October 21, 2021
October 21, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
From Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
From Benzinga
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 03, 2021
From Benzinga
65 Biggest Movers From Yesterday
September 03, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
September 02, 2021
From Benzinga
46 Stocks Moving In Thursday's Mid-Day Session
September 02, 2021
From Benzinga
Why Is Plus Therapeutics Stock Moving Higher On Thursday?
September 02, 2021
Tickers
PSTV
From Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 02, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 23, 2021
From Benzinga
From InvestorPlace
25 Stocks Moving in Monday's Pre-Market Session
August 23, 2021
From Benzinga
Why Is Plus Therapeutics Stock Rising After Data Presentation From Brain Tumor Trial?
August 23, 2021
Tickers
PSTV
From Benzinga
Plus Therapeutics Shares Preclinical Data For Targeted Cancer Radiation Therapy: Highlights
August 19, 2021
Tickers
PSTV
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.